What are the FDAs responses to injuries related to gadolinium?
The FDA’s black box warning on packaging and related literature is designed to prevent improper and illegal marketing of prescription medications by drug manufacturers. The recommended dosage of contrast agent should be administered as per the product label and to be repeated only when previously administered contrast agent is completely eliminated from the body.
